Several recent studies suggest that health outcomes are worse for remote-dwelling patients with chronic kidney disease and kidney failure, compared with otherwise similar patients living closer to specialist care. [1] [2] [3] Potential inequities in access to health care as a result of remote residence location are particularly relevant for patients treated with hemodialysiswhich for most patients requires travel to a treatment facility three times per week. The burden of travel to dialysis has been associated with a lower health-related quality of life and an increased risk of mortality for patients with longer travel times to hemodialysis compared with those with shorter travel times. 4 Rural vs. urban place of dwelling is an alternative measure of geographical access and is often used to evaluate accessibility to health care. Reported outcomes for urban-vs. rural-dwelling patients with chronic kidney disease have varied. 5, 6 In one large study from the United States, survival was comparable for rural-and urban-dwelling hemodialysis patients, although the distance or travel time to the nearest hemodialysis center was not evaluated. 7 A large US population-based study reported that the likelihood of receiving a kidney transplant (when adjusted for factors including distance from care) was slightly higher for rural compared urban dwellers. 8 An estimated one-third of dialysis units in the United States are located in rural areas. 7 As distance to specialist care may differ substantially between rural dialysis units, classifying location as rural vs. urban may not adequately capture access to care. How travel distance to the nearest hemodialysis center and urban vs. rural dwelling is related to the risk of mortality in hemodialysis patients in the United States is unknown.
Ensuring equitable access to high-quality health care for patients with kidney failure is an important objective. To achieve this objective, further examination of the association between residence location and outcomes is required. We evaluated the association between place of residence and mortality among incident hemodialysis patients in the United States using (1) the shortest driving distance to the closest hemodialysis center as determined by patient zip code and geographic information systems software and (2) the rural-urban commuting area (RUCA) code to classify the degree to which the residence location of each patient was rural or urban. We hypothesized that the risk of mortality would be higher for patients living further away from their dialysis center and for rural vs. urban dwellers.
RESULTS

Patient characteristics
Among the 747,150 patients who initiated chronic hemodialysis during the study period, information on the distance between residence location and the closest hemodialysis center could be determined for 726,347 (97.2%). The 20,803 (2.8%) patients with missing or invalid zip codes were excluded. Patients who lived further away from the closest dialysis center were less likely to be black or have hypertension as a cause of end-stage renal disease (ESRD) than patients living closer (Po0.0001; Table 1 ). When compared with patients living closest to their dialysis unit, patients living 4100 miles away had lower rates of coronary disease, peripheral vascular disease, congestive heart failure, and chronic obstructive pulmonary disease. Patients residing further from the hemodialysis center were more likely to live in a rural area. However, among patients residing in a rural area, a substantial proportion, 80.2%, lived within 25 miles of the closest hemodialysis center.
Overall, 127,605 (17.6%) of patients received a kidney transplant during follow-up. Although 26.7% of the study population changed residence location during follow-up, most patients (90.8%) remained in the same distance category throughout the study. Of the 9.2% of patients who changed distance categories during follow-up, 53.0 and 92.6% remained within 10 and 25 miles of the closest hemodialysis center, respectively. Of the 714 remote-dwelling patients, the state of residence was known for all but one patient (0.14%). The highest proportion (84.0%) lived in the West (46.5% lived in California and 13.2% resided in Nevada). Of the remaining remote dwellers, 6.7% lived in the South (Texas and Oklahoma) and 7.6% in the Midwest (Kansas, Minnesota, and North Dakota). Remote dwellers in the Northeastern region resided in Massachusetts (1.5%).
Likelihood of mortality by distance category
During the median follow-up period of 2.7 years, and 368,569 (50.7%) patients died. Table 2 shows the adjusted time to death by distance from the closest hemodialysis center. In the fully adjusted model, patients living 4100 miles from the closest dialysis center had an increased hazard of death, 1.21 (1.08, 1.37), compared with the referent group (0-10 miles). When follow-up was not censored at kidney transplantation, the increased risk of mortality in the remotedwelling group was attenuated, although the test for trend remained statistically significant (Po0.0001). The risk of death was 1.00 (0.99-1.01), 0.97 (0.95-0.99), 0.94 (0.90-0.98), and 1.07 (0.96-1.20) for distances of 11-25 miles, 26-45 miles, 46-100 miles, and 4100 miles, respectively (all compared with the referent of 0-10 miles).
In an additional analysis, we included with the main cohort the 401,184 dialysis patients who were over 70 years of age and initiated dialysis during the study period. All compared with the referent group of 0-10 miles; the risk of death for 18-to 470-year-olds was 0.99 (0.97-1.00), 0.98 (0.96-0.99), 0.96 (0.93-0.98), and 1.11 (1.02-1.21) for distances of 11-25 miles, 26-45 miles, 46-100 miles, and 4100 miles, respectively (P for trend o0.0001). When analyzed separately, patients aged 470 years and living more than 100 miles from the closest hemodialysis center had a hazard ratio for the risk of death of 1.01 (0.89, 1.14) compared with those living within 10 miles.
Tests for interaction demonstrated that age (Po0.0001), race (Po0.0001), diabetes (P ¼ 0.0149), cause of ESRD (Po0.0001), median income (Po0.0001), and insurance status (Po0.0001), but not sex (P ¼ 0.057), all significantly modified the relationship between distance from the hemodialysis center and the likelihood of death. Therefore, we performed analyses that examined the association between time to death and distance from the closest hemodialysis center, and stratified on these potential confounders ( Figure 1 ). The point estimate for mortality in the patients living furthest from the hemodialysis center (4100 miles; as compared with those living o10 miles) was only significant in the 18-to 39-and 60-to 70-year-old age categories: 1.57 (95% confidence interval 1.04-2.37) and 1.36 (1.16-1.60), respectively. Despite the positive test for interaction, the hazard ratio for mortality for those living furthest away was similar among those with (1.23 (1.06-1.44)) and without (1.24 (1.10-1.40)) diabetes as the cause of ESRD. For those with private insurance, the hazard ratio for higher mortality was 1.28 (1.01-1.63) and 1.30 (1.10-1.52) for those insured solely by Medicare.
Likelihood of mortality by rural vs. urban location of residence
After adjustment for distance from the closest hemodialysis center, there was no association between rural residence location and the risk of death (Table 3) . A borderline interaction between rural location of residence and the distance from the closest hemodialysis center was noted (P ¼ 0.052). However, the risk of death was not appreciably increased among rural dwellers than among those living in metropolitan areas within any of the distance categories ( Table 4 ). The analysis including the patients 470 years old showed no association between rural residence location and the risk of death-1.02 (1.02, 1.03) and 1.01 (1.00, 1.02) for patients residing in micropolitan and rural communities, respectively, compared with patients residing in metropolitan areas (data not shown).
DISCUSSION
To our knowledge, this is the first study to evaluate survival for a large population of hemodialysis patients in the United States
as a function of distance to the nearest hemodialysis center while also accounting for urban-rural status. Evaluation of both of these factors is potentially significant given the decentralization of dialysis services in the United States; rural status alone may not adequately measure access to care.
Patients who lived the furthest from the closest hemodialysis center (4100 miles) had a 21% increased risk of death compared with those living within 10 miles of the closest center. Although patients living further away from the closest dialysis center were more likely to live in a rural area than those living closer, 53.5% of patients living more than 100 miles from the closest dialysis unit lived in either a metropolitan (population 450,000) or a micropolitan (population 10,000-50,000) area. Furthermore, when adjusted Abbreviations: BMI, body mass index; CAD, coronary artery disease; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; CVD, cerebrovascular disease; eGFR, estimated glomerular filtration rate; ESRD, end-stage renal disease; PVD, peripheral vascular disease; RUCA, rural-urban commuting area. Data expressed as N (%), except * mean (standard deviation). Totals do not always add to 100% because of rounding. Communities were classified as: metropolitan (RUCA 1.0-3.9; cities with population of 450,000 and their associated suburban areas); micropolitan (RUCA 4.0-6.0; towns or cities with population of 10,000 to 50,000); or rural (RUCA 46.0; towns with population of o10,000). Data on eGFR, RUCA score, insurer, and median annual income were available for n=667,330, n=726,347, n=692,779, n=705,265, and n=720,647 of the study population, respectively.
for distance, rural-urban status was not significantly associated with survival. These findings suggest that remote distance (4100 miles) from the closest dialysis unit, rather than rural-urban status, better reflects the increased risk of mortality associated with residence location in US hemodialysis patients. The magnitude of the increased risk among remote dwellers was relatively small, and was attenuated when follow-up time after kidney transplantation was included. This attenuated association was anticipated given the previous information that remote dwellers (albeit evaluated as distance from a transplant center) have a higher likelihood of transplantation than those living closer, and outcomes are better following transplantation as compared with dialysis. 8 We attempted to identify factors that influenced the association between remote residence location and the risk of mortality. Despite positive tests for interaction, visual inspection of the hazards by distance category suggests that the relationship was similar in groups defined by such factors. Although we did not find an increased risk of death among remote dwellers with certain characteristics (such as diabetes; age 40-59 years; or with hypertension as the underlying cause of ESRD), it is unclear whether this represents a true difference or is due to residual confounding by unmeasured characteristics such as patient or physician preferences. The risk of death by distance from the closest dialysis center was not consistently related to age. Furthermore, we did not find that inclusion of elderly dialysis patients in the study population (age more than 70 years old) influenced the relationship between remote residence location and the risk of mortality. The inclusion of this elderly group of dialysis patients also did not increase mortality in the rural-dwelling group. It is possible that, irrespective of location, patients over the age of 70 years who initiate dialysis are a highly selected group with a lower comorbid disease burden that is unaccounted for in our analysis despite adjustment for comorbid conditions in multivariate models. In a smaller study from England, the risk of mortality was higher for incident dialysis patients over 80 years of age; however, comorbidity was a more significant predictor of outcome than age. 9 Future studies should collect detailed information on clinical characteristics such as the severity of comorbid conditions and markers of quality of care for hemodialysis patients by residence location.
Our results are in keeping with a previously published study evaluating the association between remote dwelling and survival in Canadian hemodialysis patients, 2 which found a marked increase in the risk of death from infectious causes for patients living more than 300 km away. It is possible that remote-dwelling patients in that study had higher rates of catheter use and catheter complications, which might have increased mortality; however, data regarding vascular access type were not available. Our results regarding remotedwelling status and the likelihood of kidney transplantation are consistent with another large study based on United States Renal Data System (USRDS) data showing that remote dwellers (remote from a transplant center) had a similar or higher likelihood of transplantation compared with patients living within 15 miles of the kidney transplant center. 8 We speculate that the higher likelihood of transplantation among remote dwellers from a dialysis center in the current study may be related to lower comorbid disease burden in this group, which was not accounted for in our multivariate analysis, or a higher motivation to pursue transplantation among remote dwellers because of the travel burden of dialysis.
Studies based on rural vs. urban residence have reported equivocal, 7 superior, 10 or inferior 3, 6 outcomes for rural dwellers with chronic kidney disease, compared with otherwise similar urban dwellers. A British study of 2548 dialysis patients analyzed by health authority reported the lowest mortality for rural and urban residence and highest mortality in industrial or mining health authorities. 5 The disparity in survival was not explained by other factors, including distance to dialysis center. However, this study did not censor at transplantation, and the majority of patients were treated with peritoneal dialysis rather than in-center hemodialysis. Our study included all adult patients starting hemodialysis over a 12-year period in the United States. We adjusted for a number of patient and socioeconomic factors and RUCA score, and also accounted for any potential disparities in access to transplant by censoring at transplantation.
It is possible that hemodialysis patients living far from their dialysis unit have a higher burden of comorbid conditions than those living closer. However, in our study, patients living the furthest away had the lowest rates of Figure 1 | The figure shows the adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) associated with the likelihood of mortality by distance to the closest hemodialysis center (all compared with the referent group of those living within 10 miles). Models are censored at the time of kidney transplantation and adjusted for patient age, gender, race, cause of end-stage renal disease (ESRD), diabetic status, median within-neighborhood household income, insurance status, current smoking status, ambulatory status, comorbid conditions (coronary artery disease, peripheral vascular disease, cerebrovascular disease, congestive heart failure, malignancy, chronic obstructive pulmonary disease, alcohol or drug dependence), body mass index, and estimated glomerular filtration rate at dialysis initiation. Tests for interaction were significant at Po0.0001 for age, race, insurance status, median annual income, cause of ESRD, and at P ¼ 0.0149 for diabetic status.
o
Residence location and dialysis measured comorbid conditions. There was a modest increase in the risk of mortality for remote-dwelling patients with ESRD secondary to diabetes compared with those patients living closest to their dialysis center, suggesting that the higher mortality could be related to decreased physician or health-service access. Yet, just over half of the patients in this category lived in either a micropolitan or metropolitan area where better access to physicians and health services would be expected, as compared with rural areas. A potential explanation for our results is that the longer distance to travel to a dialysis center may cause patients to miss or shorten a dialysis session. Moist et al. 4 reported a 20% greater risk of death for patients with a travel time to dialysis greater than 60 min compared with those patients with a travel time of 15 min or less. Among patients with longer travel times, transportation issues were identified as a frequent reason to skip or shorten a dialysis session. Both skipping 11 and shortening 12 dialysis sessions have been associated with increased mortality.
Our study has several limitations. The distance calculations are based on zip codes and only approximate the true distance; to minimize bias, we used broad distance categories. We excluded people without a valid zip code, although this group accounted for less than 3% of the study population. We used each patient's zip code at the time of dialysis initiation to classify residence location, and this method could misclassify patients who moved during the study. However, at follow-up, 90.8% of the patients had remained in the same distance category. Given that a minority of patients move further away from specialty care once starting dialysis, 2 the true risk of death among remote-dwelling patients would therefore be expected to underestimate mortality in this group. Remote residence location has been associated with a lower risk of initiating dialysis, although we would that expect this effect would also bias the results toward the nullwith only healthier remote-dwelling patients initiating dialysis. 3 We were unable to reliably identify patients' performing their own dialysis at home, and such patients were therefore included in the analysis. However, as the number of such patients in the United States is low (1756 at the approximate middle point of our study period), this is unlikely to have affected our conclusions. 13 Our analysis did not account for changes in dialysis modality that may have occurred after the initiation of hemodialysis. However, on the basis USRDS data, the probability of a change in modality does not differ significantly by rural-urban location. 14 We did not have individual-level data on socioeconomic status, and because our primary geolocalizing variable was based on zip code we could not use more precise methods such as block area addresses to categorize participants with respect to socioeconomic status. However, results were similar when an alternative method of adjusting for income (based on zip code tabulation areas) was used instead (data not shown). We did not evaluate travel time as a geographical barrier to access, and it is possible that patients using public transportation to travel to a dialysis unit would require a similar amount of travel time as remote-dwelling patients using private transportation. Although the optimal method of measuring geographical access is unknown, we evaluated distance by road to the closest dialysis center as it is an objective determination of geographical access, which is highly correlated with travel time. 15 Finally, we did not have information on the actual dialysis unit at which patients received care, and therefore assumed that patients attended the closest dialysis center.
In conclusion, we found that mortality was higher for hemodialysis patients living more than 100 miles from the closest dialysis center compared with those living closer. In contrast, there was no evidence that the likelihood of death was higher among rural-dwelling compared with urbandwelling patients. Although the number of remote-dwelling hemodialysis patients in the United States is relatively small, our results indicate that future studies should evaluate the specific factors that are related to travel distance, such as cost, time, and access to transportation-as well as assessing the quality of care in these patients.
MATERIALS AND METHODS Study population and data sources
Data from the USRDS were used for this study, which was approved by the local research ethics review board at the University of Alberta. We studied incident adult patients, aged 18 to 70 years, who initiated chronic hemodialysis between 1 January 1995 and 30 September 2007 in the continental United States. The USRDS provides the zip code for each patient's residence location at the time of first renal replacement (dialysis or transplantation), as well as a listing of centers providing chronic hemodialysis and their zip codes. The population of each zip code was obtained using data from the 2000 US census and mapped onto zip-code tabulation areas. 16 Estimation of distance The geographic coordinates for each five-digit zip code were determined using the USA 5-digit ZIP Code Database (ZIP Code Download, Provo, Utah). These coordinates were entered into the ArcGIS 9.2 software (ESRI Incorporated, Redlands, CA) to determine the shortest distance by road (in miles) between the closest hemodialysis center and the residence of each patient at initiation of hemodialysis. [17] [18] [19] Distance to the closest hemodialysis center was categorized corresponding to the 0-75th 475-95th 495-99th 499-99.9th 4 and 499.9th percentiles. To assess the impact of changes in residence location over time, patients were categorized into distance categories as above using the zip code associated with their residence at the time of the last follow-up. Patient residence data were only available at the zip-code level, and thus a change in residence location was defined as a move to another zip code.
Classification of rural status
We used the RUCA code to classify the extent to which the residence location of each patient was rural or urban. 20 RUCA codes are assigned to each US zip code based on markers of population density, with values ranging from 1.0 (most urban) to 10.6 (most rural). Information on population density is supplemented by data on employment commuting to ensure that suburban areas with low population density in which many residents work in nearby large urban areas are classified as urban. As in previous work, 20 we classified each patient in the current analysis as belonging to 1 of 3 mutually exclusive RUCA groups: metropolitan (RUCA 1.0-3.9; cities with population of 450,000 and their associated suburban areas); micropolitan (RUCA 4.0-6.0; towns or cities with population of 10,000 to 50,000; and rural (RUCA 46.0; towns with population of o10,000).
Statistical analyses
Time to mortality was determined from the date of first renal replacement using the Kaplan-Meier method, and group differences were compared with the log-rank test. Patients were followed up until death or until the end of follow-up (30 September 2007) and censored after time of kidney transplantation. To evaluate the effect of transplantation on survival according to patient location, we conducted a sensitivity analysis that did not censor participants at kidney transplantation. Cox multivariate regression analysis was performed to determine the likelihood of mortality among patients in the different distance categories after adjustment for the following potential confounders: patient age, gender, race (as submitted to the USRDS on the initial Medical Evidence form: white, Black, American Indian, other), cause of ESRD (diabetes, glomerulonephritis, hypertension, other causes), median withinneighborhood household income (determined by linkage of patient zip codes to data from the 2000 US census), insurance status (Medicare only; private insurance only; insured by Department of Veterans' Affairs, other or no insurance), current smoking status, ambulatory status, comorbid conditions (coronary artery disease, peripheral vascular disease, cerebrovascular disease, congestive heart failure, malignancy, chronic obstructive pulmonary disease, alcohol or drug dependence), body mass index, and estimated glomerular filtration rate at dialysis initiation. In cases in which data were missing, a category of unknown was created and entered into the model. To assess the influence of clinically relevant patient characteristics on the risk of mortality by distance, we repeated analyses in subgroups defined by combinations of age o50 years, absence of diabetes, insurance status, and rural-urban residence location.
Tests for interaction were performed using cross-product terms in the Cox proportional hazards models. The proportional hazards assumption was tested using log-negative log plots of the withingroup survivorship probabilities vs. log-time as well as timedependent covariates in the Cox model. Statistical significance was set at Po0.05, and all statistical tests were two sided. Analyses were performed with SAS version 9.1 (SAS Institute, Cary, NC) and S-PLUS version 7.0 (TIBCO Software, Palo Alto, CA).
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